| Bioactivity | 1,9-Dihydro-9-β-D-xylofuranosyl-6H-purin-6-one is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 1,9-Dihydro-9-β-D-xylofuranosyl-6H-purin-6-one |
| CAS | 10517-16-5 |
| Formula | C10H12N4O5 |
| Molar Mass | 268.23 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
1,9-Dihydro-9-β-D-xylofuranosyl-6H-purin-6-one
CAS: 10517-16-5 F: C10H12N4O5 W: 268.23
1,9-Dihydro-9-β-D-xylofuranosyl-6H-purin-6-one is a purine nucleoside analog. Purine nucleoside analogs have broad anti
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.